Chung Ho Park, a member of KKR’s private equity team and co-head of the firm’s Korea business, has been promoted to partner level. A further seven Asia-based professionals, across different strategies, were named managing directors.
Park has been with KKR since 2009, joining the firm from TPG Capital, where he was involved in PE deals in Australia, Japan, Korea, and Southeast Asia. He has played a role in KKR investments such as Oriental...
Chinese gene therapy specialist Exegenesis Bio has received $20 million in Series B funding led by Legend Capital. It will be used to support clinical development of the company’s drug portfolio.
Alibaba Group has led a $300 million round for Chinese electric vehicle (EV) manufacturer Xpeng Motors. It comes barely two weeks after the company closed an extended Series C round of $500 million.
EDBI, the investment arm of Singapore’s Economic Development Board, has invested in Vesta, a US-based fraud and payment technology start-up with ambitions to expand into Asia.
Hana Financial has invested KRW100 billion ($85 million) in a portfolio of Korean waste to energy (WTE) projects controlled by Global Infrastructure Partners (GIP).